| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $18.6M | +96.8% |
| SG&A Expense | $17.6M | -0.6% |
| Operating Income | -$57.3M | -65.5% |
| Pre-tax Income | -$56.7M | -79.7% |
| Income Tax | $87K | -55.8% |
| Net Income | -$56.8M | -81.1% |
| EPS (Basic) | -$1.31 | -56.0% |
| EPS (Diluted) | -$1.31 | -56.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $44.0M | -43.1% |
| Total Assets | $114.5M | -31.8% |
| Current Liabilities | $7.3M | -24.0% |
| Long-term Debt | $14.3M | +6.6% |
| Total Liabilities | $84.3M | +1.8% |
| Stockholders' Equity | $30.1M | -64.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.9M | -74.4% |
| Capital Expenditures | $257K | +60.6% |
| Investing Cash Flow | $21.9M | +480.5% |
| Financing Cash Flow | -$4.8M | -3439.2% |
| Free Cash Flow | -$32.2M | -74.3% |